{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.3616.200.110.102.6288","meta":{"versionId":"5","lastUpdated":"2020-12-24T01:01:08.000-05:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3616.200.110.102.6288","version":"20201224","name":"COVID19 SNOMED Value Set for Intravesical Administration of Therapeutic Agent","status":"active","date":"2020-12-24T01:01:08-05:00","publisher":"Clinical Architecture","compose":{"include":[{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20220301","concept":[{"code":"301879009","display":"Instillation of bacillus Calmette-Guerin into the bladder (procedure)"},{"code":"44194005","display":"Urinary bladder instillation of anticarcinogenic agent (procedure)"},{"code":"443199009","display":"Instillation of mitomycin C into bladder (procedure)"},{"code":"712753009","display":"Administration of chemotherapeutic agent into bladder via intravesical route (procedure)"}]}]}}